Beyond Inc Acquires Buy Buy Baby Brand Rights Reuniting with Bed Bath Beyond Broadening Inflation Pressures Beyond Iran and Oil Consumers Face Reacceleration in Multiple Categories Oppenheimer Upgrades Outlook on Marvell Technology With Price Target Boost Wall Street Hits New Peaks Nasdaq and Micron Set Records United Airlines Taps Starlink Applied Digital Reports Fiscal Third Quarter 2026 Results AI Infrastructure Demand in Focus Micron Reaches 1 Trillion Market Cap on AIDriven Memory Demand Surge LSF Q1 2026 Earnings Stunning EPS Beat Defies Expectations Stock Slips Paranovus Entertainment Technology Ltd PAVS Q2 2022 Earnings Massive EPS Miss Highlights Severe Operational Challenges Ames National Corporation ATLO Q1 2026 Earnings Solid EPS Beat Amid Stable Operations Porch Group Q1 2026 Earnings EPS Surprises with 47 Beat Amid Revenue Discretion Senti Biosciences Q1 2026 Earnings Narrower Loss than Expected Stock Edges Up Ohio Valley Banc Corp Q3 2025 Earnings Solid Earnings Delivery Amid Steady Operating Environment Lumexa Imaging Holdings Inc LMRI Dips 22 Approaching Key Support at 76 FTAI Aviation Ltd FTAI Surges 23 as Aerospace Momentum Builds Tests Key Resistance Zone TPG Mortgage Investment Trust MITT Edges Lower as Yield Concerns Persist CNFinance Holdings CNF Edges Lower Navigating Support in a Tight Range Aclaris Therapeutics ACRS Edges Lower Amid Tight Trading Range Vishay Intertechnology Reports Q1 2026 Revenue of 8392 Million Returns to Profitability US Seeks to Expand AI Integration in Asia Following TrumpXi Talks Iran Israel and Arab nations are bound by a new balance of terror Novartis Raises Annual Sales and Profit Guidance Amid Strong Operational Momentum Venture Capital Turns to Boring Businesses AI and Dealmaking Reshape Accounting and Property Management US Economy Expanded at Sluggish 05 in Q4 Government Downgrades Estimate Burberry CEO Joshua Schulman Eyes 122m Pay Package as Luxury Brand Softens Climate Targets SFIX Q1 2026 Earnings NarrowerThanExpected Loss Signals Cost Control Progress Harvard Bioscience Slips as Traders Assess Support Levels HBIO Down Nearly 3